Box 3.
Drugs associated with gynaecomastia
| Anti-androgen | 5-α reductase inhibitors (finasteride) |
| Antihypertensive | Calcium channel blockers, spironolactone, angiotensin-converting enzyme (ACE) inhibitors |
| Antiretroviral | Protease inhibitors, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs) |
| Antifungal/-microbial | Ketoconazole, metronidazole, isoniazid |
| Antipsychotic | Haloperidol, olanzapine, risperidone, ziprasidone, paliperidone, fluoxetine, gabapentin, pregabalin, venlafaxine, aripiprazole, diazepam, amisulpride, quetiapine |
| Antiparasite | Phenothrin |
| Analgesics | Opioids |
| Cardiovascular | Digoxin, amiodarone, statins, clonidine, clopidogrel, sildenafil |
| Chemotherapy drug | Methotrexate, alkylating agents, cisplatin, vincristine, bleomycin, dasatinib, imatinib |
| Exogenous hormones | Oestrogens, steroids, androgens |
| Gastrointestinal drug | Proton pump inhibitors, H2 histamine blockers, domperidone, misoprostol |
| Illicit and recreational | Amphetamines, cannabis, heroin, methadone, alcohol |
| Herbal supplements | Lavender, soy protein, tea tree oil, tribulus, common nettle |
| Other | Theophylline, penicillamine, ivacaftor, gonadotrophin-releasing agents |